blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1568709

EP1568709 - Purification of fibrinogen [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.03.2012
Database last updated on 24.04.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
CSL Behring GmbH
Emil-von-Behring-Strasse 76
35041 Marburg / DE
[2007/12]
Former [2005/35]For all designated states
ZLB Behring GmbH
Emil-von-Behring-Strasse 76
35041 Marburg / DE
Inventor(s)01 / Metzner, Hubert
Im Boden 6
35041 Marburg / DE
02 / Liebing, Uwe
Kasseler Strasse 46
35091 Coelbe / DE
03 / Feussner, Annette
Langewiesenweg 10
35043 Marburg / DE
04 / Lemmer, Joerg
Wermertshaeuserstrasse 10
35085 Ebsdorfergrund / DE
05 / Schulte, Stefan
Bauerbacher Strasse 46
35043 Marburg / DE
06 / Gawantka, Volker
Am Damm 5
35094 Lahntal / DE
 [2005/35]
Application number, filing date05003017.012.02.2005
[2005/35]
Priority number, dateDE2004100940024.02.2004         Original published format: DE102004009400
[2005/35]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP1568709
Date:31.08.2005
Language:DE
[2005/35]
Type: A3 Search report 
No.:EP1568709
Date:02.11.2005
[2005/44]
Type: B1 Patent specification 
No.:EP1568709
Date:11.05.2011
Language:DE
[2011/19]
Search report(s)(Supplementary) European search report - dispatched on:EP15.09.2005
ClassificationIPC:C07K14/75
[2005/35]
CPC:
C07K14/75 (EP,US); A61C3/06 (KR); A46B15/0032 (KR);
A46B7/04 (KR); A46B9/04 (KR); A61P7/00 (EP);
A61P7/04 (EP); A46B2200/1066 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2005/35]
TitleGerman:Reinigung von Fibrinogen[2005/35]
English:Purification of fibrinogen[2005/35]
French:Purification du fibrinogène[2005/35]
Examination procedure02.05.2006Examination requested  [2006/24]
28.09.2006Despatch of a communication from the examining division (Time limit: M04)
30.01.2007Reply to a communication from the examining division
20.12.2007Despatch of a communication from the examining division (Time limit: M04)
23.04.2008Reply to a communication from the examining division
19.01.2009Despatch of a communication from the examining division (Time limit: M06)
24.07.2009Reply to a communication from the examining division
29.03.2010Cancellation of oral proceeding that was planned for 26.04.2010
21.04.2010Despatch of a communication from the examining division (Time limit: M02)
26.04.2010Date of oral proceedings (cancelled)
23.06.2010Reply to a communication from the examining division
03.09.2010Communication of intention to grant the patent
13.01.2011Fee for grant paid
13.01.2011Fee for publishing/printing paid
Divisional application(s)EP10182320.1  / EP2264069
EP10183940.5  / EP2267025
Opposition(s)14.02.2012No opposition filed within time limit [2012/16]
Fees paidRenewal fee
28.02.2007Renewal fee patent year 03
29.02.2008Renewal fee patent year 04
02.03.2009Renewal fee patent year 05
01.03.2010Renewal fee patent year 06
28.02.2011Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.02.2005
CY11.05.2011
CZ11.05.2011
EE11.05.2011
FI11.05.2011
LT11.05.2011
RO11.05.2011
SI11.05.2011
SK11.05.2011
BG11.08.2011
GR12.08.2011
IS11.09.2011
PT12.09.2011
[2014/34]
Former [2013/29]CY11.05.2011
CZ11.05.2011
EE11.05.2011
FI11.05.2011
LT11.05.2011
RO11.05.2011
SI11.05.2011
SK11.05.2011
BG11.08.2011
GR12.08.2011
IS11.09.2011
PT12.09.2011
Former [2012/10]CY11.05.2011
CZ11.05.2011
EE11.05.2011
FI11.05.2011
LT11.05.2011
RO11.05.2011
SI11.05.2011
SK11.05.2011
GR12.08.2011
IS11.09.2011
PT12.09.2011
Former [2012/09]CY11.05.2011
CZ11.05.2011
EE11.05.2011
FI11.05.2011
LT11.05.2011
SI11.05.2011
GR12.08.2011
IS11.09.2011
PT12.09.2011
Former [2011/50]CY11.05.2011
FI11.05.2011
LT11.05.2011
SI11.05.2011
GR12.08.2011
IS11.09.2011
PT12.09.2011
Former [2011/49]CY11.05.2011
FI11.05.2011
LT11.05.2011
GR12.08.2011
PT12.09.2011
Former [2011/47]LT11.05.2011
PT12.09.2011
Documents cited:Search[X]US4096136  (AYERS JOHN STEPHEN, et al) [X] 1,2,9-23,26 * das gesamte Dokument, insbesondere Spalten 1 and 2, Beispiel 3 und die Ansprüche *;
 [XD]DE2903131  (BIOTEST SERUM INSTITUT GMBH) [XD] 19-26 * page 15; examples 1,3; claim 1 *;
 [X]EP0311950  (BIOTEST PHARMA GMBH [DE]) [X] 19-26 * page 2, line 54 - page 3, line 12 *;
 [AD]EP0366946  (NEW YORK BLOOD CENTER INC [US]) [AD] * page 4 - page 6; claims 1,10 *;
 [XD]WO9305067  (BAXTER INT [US]) [XD] 19-26 * page 7, line 4 - line 20; example 1; claim 1 *;
 [XD]WO0017234  (PPL THERAPEUTICS SCOTLAND LTD [GB], et al) [XD] 19-26 * page 10, line 23 - page 11, line 24; example 1; claim 1 *;
 [XD]WO0127623  (VI TECHNOLOGIES INC [US], et al) [XD] 19-26 * page 2 - page 3; claims 1,11 *;
 [X]WO2004007533  (NAT BLOOD AUTHORITY [GB], et al) [X] 19-26 * page 4 - page 5; example 4; claims 1,15-20 *;
 [X]  - JENNISSEN HP, "Critical hydrophobicity HIC", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (2003), Database accession no. PREV200300401530, XP002342368 [X] 19-26 * column A *
 [A]  - GOHEEN S C ET AL, "Protein losses in ion-exchange and hydrophobic interaction high-performance liquid chromatography", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, (20000818), vol. 890, no. 1, ISSN 0021-9673, pages 73 - 80, XP004228911 [A] * page 77; figures 3,4 *

DOI:   http://dx.doi.org/10.1016/S0021-9673(00)00572-0
    [ ] - FASEB JOURNAL, (200303), vol. 17, no. 4-5, ISSN 0892-6638, page 631.14
ExaminationUS6037457
    - LOTTSPEICH; ZORBAS (HERAUSGEBER), Bioanalytik, HEIDELBERG, BERLIN (DE), SPEKTRUM AKADEMISCHER VERLAG, (19980101), pages 42 - 44
    - SCOPES R.K., Protein Purification, Principles and Practice, SPRINGER VERLAG, (19940101), page 46
    - LANGER B.G. ET AL, "Deglycosylation of Fibrinogen Accelerates Polymerization and Increases Lateral Aggregation of Fibrin Fibers", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (19881015), vol. 263, no. 29, pages 15056 - 15063
    - MOSESSON M.W.; FINLAYSON J.S., "Preparation and analysis of fibrinogen subfractions", J. LAB. & CLIN. MED., (19631001), vol. 63, no. 4, pages 663 - 674
by applicantDE2636757
 DE2903131
 US4188318
 US4210580
 DE2902158
 EP0103196
 EP0173242
 WO8912065
 EP0359593
 EP0366946
 EP0383234
 WO9012803
 EP0408029
 WO9101808
 US5043428
 US5094960
 US5099003
 US5138034
 WO9305067
 EP0555135
 WO9317776
 US5252709
 WO9525748
 WO9602571
 US5639940
 EP0789030
 US5723579
 US5773033
 US5783663
 US5834420
 WO9905176
 WO9920655
 WO9937680
 WO9951724
 US6037457
 WO0017234
 WO0017239
 WO0127623
 WO0148016
    - JAKOBSEN; KIERULF, THROMBOSIS RESEARCH, (1973), vol. 3, pages 145 - 159
    - TAKEDA, JOURNAL OF CLINICAL INVESTIGATION, (1966), vol. 45, pages 103 - 111
    - VILA ET AL., THROMBOSIS RESEARCH, (1985), vol. 39, pages 651 - 656
    - BLOMBäCK; BLOMBäCK, ARKIV FöR KEMI, (1956), vol. 10, pages 415 - 443
    - SUZUKI ET AL., THROMBOSIS RESEARCH, (1980), vol. 18, pages 707 - 715
    - DEMPFLE; HEENE, THROMBOSIS RESEARCH, (1987), vol. 46, pages 19 - 27
    - VUENTO; VAHERI, BIOCHEM. J., (1979), vol. 183, pages 331 - 337
    - DEUTSCH; MERTZ, SCIENCE, (1970), vol. 170, pages 1095 - 1096
    - MATSUDA ET AL., THROMBOSIS RESEARCH, (1972), vol. 1, pages 619 - 630
    - SCOTT ET AL., ARCH BIOCHEM BIOPHYS, (1986), vol. 249, pages 480 - 488
    - ACTA-HAEMATOL., (1957), vol. 17, pages 237 - 246
    - SIERRA, JOURNAL OF BIOMATERIALS APPLICATIONS, (1993), vol. 7, pages 309 - 352
    - MARTINOWITZ; SPOTNITZ, THROMBOSIS AND HAEMOSTASIS, (1997), vol. 78, pages 661 - 666
    - RADOSEVICH ET AL., VOX SANGUINIS, (1997), vol. 72, pages 133 - 143
    - M.G. SCHLAG; R. HOPF; U. ZIFKO; H. REDL, ACTA NEUROCHIR, (2002), vol. 144, pages 63 - 69
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.